Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.35), $0.44 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.